Pharmaceutical industry
European Medicines Agency Approves Duloxetine for Depression Treatment
The European Medicines Agency's Committee for Medicinal Products in Human Use (CHMP) has issued a positive opinion recommending approval of duloxetine for the treatment of major depressive episodes. This decision is a significant milestone in the development and marketing of duloxetine, which is expected to be authorized for